- Home
- BBIO vs HTHT Comparison
BBIO vs HTHT Comparison
Compare BBIO & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | HTHT |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.6B |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BBIO | HTHT |
|---|---|---|
| Price | $70.41 | $42.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 25 | 4 |
| Target Price | ★ $86.33 | $56.60 |
| AVG Volume (30 Days) | ★ 2.7M | 2.4M |
| Earning Date | 05-12-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | $7.18 |
| Revenue Next Year | $73.78 | $6.71 |
| P/E Ratio | ★ N/A | $30.34 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $41.80 | $30.42 |
| 52 Week High | $84.94 | $56.53 |
Technical Indicators
Market Signals| Indicator | BBIO | HTHT |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 36.46 |
| Support Level | $62.39 | $42.07 |
| Resistance Level | $71.74 | $45.65 |
| Average True Range (ATR) | 2.32 | 1.26 |
| MACD | 0.47 | -0.07 |
| Stochastic Oscillator | 67.48 | 31.81 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About HTHT H World Group Limited
H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.